Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) for Arterial Stiffness

C

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Darterial\u002Dstiffness'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

The Bottom Line

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

Key Statistics

2

Studies

100

Participants

Positive

C

Grade

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
250-500 mg/day
antiagingprotocols:
500-1,000 mg/day

Upper limit: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Best taken: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability

Safety & Side Effects

Reported Side Effects

  • Generally well-tolerated
  • Mild gastrointestinal discomfort
  • Flushing (rare)
  • Headache (rare)

Known Interactions

  • May interact with NAD+-dependent medications
  • Theoretical interaction with diabetes medications (may affect glucose metabolism)

Tolerable upper intake: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does NMN (Nicotinamide Mononucleotide) help with Arterial Stiffness?
Based on 2 studies with 100 participants, there is limited but promising evidence that NMN (Nicotinamide Mononucleotide) may support Arterial Stiffness management. Our evidence grade is C (Some Evidence).
How much NMN (Nicotinamide Mononucleotide) should I take for Arterial Stiffness?
Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of NMN (Nicotinamide Mononucleotide)?
Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Arterial Stiffness?
We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Related Evidence

Other ingredients for Arterial Stiffness

NMN (Nicotinamide Mononucleotide) for other conditions

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.